Among these, ER+/HER2− luminal breast cancer is divided into luminal A and luminal B subtypes based on the KI-67 nuclear molecular marker, according to whether this nuclear molecular marker is <25% or >25%, respectively [1]. The gene discussed is ESR1; the disease is breast carcinoma.